11 results on '"A. M. Sidoti"'
Search Results
2. Attention Deficit and Hyperactivity Disorders in the Offspring of Mothers Exposed to Mild-Moderate Iodine Deficiency: A Possible Novel Iodine Deficiency Disorder in Developed Countries
- Author
-
G. Scaffidi, A. Crisà, Mariacarla Moleti, M. Sidoti, Maria Grazia Castagna, A. Artemisia, Francesco Trimarchi, V. Lo Presti, Gaetano Tortorella, Francesco Vermiglio, Maria Antonia Violi, and Filiberto Mattina
- Subjects
medicine.medical_specialty ,Offspring ,Endocrinology, Diabetes and Metabolism ,Intelligence ,Clinical Biochemistry ,Thyroid Gland ,Biochemistry ,Thyroid function tests ,Endocrinology ,Pregnancy ,Internal medicine ,medicine ,ADHD ,Humans ,Attention deficit hyperactivity disorder ,Child ,Preschool ,Attention deficit and hyperactivity disorder ,iodine deficiency ,Gestational thyroid insufficiency ,medicine.diagnostic_test ,business.industry ,Mental Disorders ,Developed Countries ,Biochemistry (medical) ,Thyroid ,Infant ,medicine.disease ,Iodine deficiency ,Pregnancy Complications ,Attention Deficit Disorder with Hyperactivity ,Case-Control Studies ,Child, Preschool ,Deficiency Diseases ,Female ,Iodine ,Italy ,Nervous System Diseases ,medicine.anatomical_structure ,Gestation ,Thyroid function ,business ,Hormone - Abstract
Over a period of almost 10 yr, we carried out a prospective study of the neuropsychological development of the offspring of 16 women from a moderately iodine-deficient area (area A) and of 11 control women from a marginally iodine-sufficient area (area B) whose thyroid function had been monitored during early gestation. Attention deficit and hyperactivity disorder (ADHD) was diagnosed in 11 of 16 area A children (68.7%) but in none from area B. Total intelligence quotient score was lower in area A than in area B children (92.1 +/- 7.8 vs. 110 +/- 10) and in ADHD children when compared with both non-ADHD children from the same area and control children (88.0 +/- 6.9 vs. 99.0 +/- 2.0 and 110 +/- 10, respectively). Seven of 11 ADHD children (63.6%) were born to the seven of eight area A mothers who became hypothyroxinemic at early gestation, whereas only one of five non-ADHD children was born to a woman who was hypothyroxinemic at 20 wk of gestation. So far, a similar prevalence of ADHD has been reported only in children with generalized resistance to thyroid hormones. This might suggest a common ADHD pathogenetic mechanism consisting either of reduced sensitivity of the nuclear receptors to thyroid hormone (generalized resistance to thyroid hormones) or reduced availability of intracellular T3 for nuclear receptor binding. The latter would be the ultimate consequence of maternal hypothyroxinemia (due to iodine deficiency), resulting in a critical reduction of the source of the intracellular T3 available to the developing fetal brain.
- Published
- 2004
- Full Text
- View/download PDF
3. Comments and Reply on: 'Study of multi-muon events produced in pp̄ interactions at √s = 1.96 TeV'; T. Aaltonen et al. (The CDF collaboration)
- Author
-
Bethke, S. Aaltonen, T. Adelman, J. Álvarez González, B. Amerio, S. Amidei, D. Anastassov, A. Antos, J. Apollinari, G. Apresyan, A. Arisawa, T. Artikov, A. Ashmanskas, W. Azzurri, P. Badgett, W. Barnett, B.A. Bartsch, V. Beecher, D. Behari, S. Bellettini, G. Benjamin, D. Bisello, D. Bizjak, I. Blocker, C. Blumenfeld, B. Bocci, A. Boisvert, V. Bolla, G. Bortoletto, D. Boudreau, J. Bridgeman, A. Brigliadori, L. Bromberg, C. Brubaker, E. Budagov, J. Budd, H.S. Budd, S. Burke, S. Burkett, K. Busetto, G. Bussey, P. Byrum, K.L. Cabrera, S. Calancha, C. Campanelli, M. Canelli, F. Carls, B. Carosi, R. Carrillo, S. Casal, B. Casarsa, M. Castro, A. Catastini, P. Cauz, D. Cavaliere, V. Chang, S.H. Chen, Y.C. Chertok, M. Chiarelli, G. Chlachidze, G. Cho, K. Chokheli, D. Chou, J.P. Chung, K. Chung, Y.S. Ciobanu, C.I. Ciocci, M.A. Clark, A. Clark, D. Compostella, G. Convery, M.E. Conway, J. Cordelli, M. Cortiana, G. Cox, C.A. Cox, D.J. Crescioli, F. Cuenca Almenar, C. Cuevas, J. Cully, J.C. Dagenhart, D. Datta, M. Davies, T. de Barbaro, P. Dell'Orso, M. Demortier, L. Deng, J. Deninno, M. di Giovanni, G.P. Di Ruzza, B. Dittmann, J.R. Donati, S. Donini, J. Dorigo, T. Efron, J. Erbacher, R. Errede, D. Errede, S. Eusebi, R. Fedorko, W.T. Fernandez, J.P. Field, R. Flanagan, G. Forrest, R. Frank, M.J. Franklin, M. Freeman, J.C. Furic, I. Gallinaro, M. Galyardt, J. Garberson, F. Garcia, J.E. Garfinkel, A.F. Genser, K. Gerberich, H. Gerdes, D. Giakoumopoulou, V. Giannetti, P. Gibson, K. Gimmell, J.L. Ginsburg, C.M. Giokaris, N. Giordani, M. Giromini, P. Giurgiu, G. Glagolev, V. Glenzinski, D. Goldschmidt, N. Golossanov, A. Gomez, G. Goncharov, M. González, O. Gorelov, I. Goshaw, A.T. Goulianos, K. Gresele, A. Grinstein, S. Guimaraes da Costa, J. Gunay-Unalan, Z. Hahn, K. Hahn, S.R. Han, B.-Y. Han, J.Y. Happacher, F. Hare, M. Harris, R.M. Hartz, M. Hatakeyama, K. Hewamanage, S. Hidas, D. Hill, C.S. Hocker, A. Hou, S. Hughes, R.E. Huston, J. Incandela, J. Ivanov, A. Jeon, E.J. Jha, M.K. Jindariani, S. Johnson, W. Jones, M. Joo, K.K. Jun, S.Y. Jung, J.E. Kar, D. Kato, Y. Kilminster, B. Kim, D.H. Kim, H.S. Kim, H.W. Kim, J.E. Kim, M.J. Kim, S.B. Kim, Y.K. Kirsch, L. Klimenko, S. Knuteson, B. Ko, B.R. Kong, D.J. Konigsberg, J. Korytov, A. Krop, D. Krumnack, N. Kruse, M. Krutelyov, V. Kulkarni, N.P. Kusakabe, Y. Kwang, S. Laasanen, A.T. Lami, S. Lander, R.L. Lannon, K. Latino, G. Lazzizzera, I. Lee, H.S. Leone, S. Lindgren, M. Lister, A. Litvintsev, D.O. Loreti, M. Lovas, L. Lucchesi, D. Lukens, P. Lungu, G. Lysak, R. Madrak, R. Maeshima, K. Makhoul, K. Maki, T. Maksimovic, P. Manousakis-Katsikakis, A. Margaroli, F. Marino, C.P. Martin, V. Martínez-Ballarín, R. Mathis, M. Mazzanti, P. Mehtala, P. Merkel, P. Mesropian, C. Miao, T. Miladinovic, N. Miller, R. Mills, C. Mitra, A. Mitselmakher, G. Moggi, N. Moon, C.S. Moore, R. Mukherjee, A. Mumford, R. Mussini, M. Nachtman, J. Nakano, I. Napier, A. Necula, V. Norniella, O. Nurse, E. Oh, S.H. Oh, Y.D. Oksuzian, I. Okusawa, T. Orava, R. Pagan Griso, S. Palencia, E. Papadimitriou, V. Paramonov, A.A. Parks, B. Pauletta, G. Paulini, M. Pellett, D.E. Penzo, A. Phillips, T.J. Piacentino, G. Pinera, L. Pitts, K. Poukhov, O. Prakoshyn, F. Pronko, A. Ptohos, F. Pueschel, E. Rahaman, A. Ranjan, N. Redondo, I. Rekovic, V. Rimondi, F. Robson, A. Rodrigo, T. Rogers, E. Rolli, S. Roser, R. Rossi, M. Rossin, R. Ruiz, A. Russ, J. Rusu, V. Sakumoto, W.K. Santi, L. Sato, K. Savoy-Navarro, A. Schlabach, P. Schmidt, E.E. Schmidt, M.A. Schmitt, M. Schwarz, T. Scodellaro, L. Sedov, A. Seidel, S. Seiya, Y. Semenov, A. Sexton-Kennedy, L. Sforza, F. Sfyrla, A. Shalhout, S.Z. Shiraishi, S. Shochet, M. Sidoti, A. Sisakyan, A. Slaughter, A.J. Slaunwhite, J. Sliwa, K. Smith, J.R. Soha, A. Sorin, V. Squillacioti, P. Denis, R.S. Stentz, D. Strologas, J. Strycker, G.L. Suh, J.S. Sukhanov, A. Suslov, I. Takashima, R. Tanaka, R. Tecchio, M. Teng, P.K. Terashi, K. Thom, J. Thompson, A.S. Thompson, G.A. Ttito-Guzmán, P. Tokar, S. Tollefson, K. Torre, S. Torretta, D. Totaro, P. Tourneur, S. Trovato, M. Tsai, S.-Y. Vallecorsa, S. van Remortel, N. Varganov, A. Vataga, E. Vázquez, F. Velev, G. Vellidis, C. Veszpremi, V. Vidal, M. Vidal, R. Vila, I. Vilar, R. Vine, T. Vogel, M. Volpi, G. Wagner, R.G. Wagner, R.L. Wakisaka, T. Wang, S.M. Whitehouse, B. Wicklund, E. Wilbur, S. Wittich, P. Wolbers, S. Wolfe, C. Wright, T. Wu, X. Yamamoto, K. Yang, U.K. Yang, Y.C. Yorita, K. Yoshida, T. Yu, G.B. Yu, I. Yu, S.S. Yun, J.C. Zanetti, A. Zhang, X. Zucchelli, S.
- Abstract
The European Physical Journal C-Particles and Fields-publishes scientific manuscripts of relevance to the scientific community following careful and strict peer reviewing and, whenever appropriate and necessary, through discussion with the authors, so as to optimise scientific content and style of presentation prior to publication. In some cases significant disagreement between authors and referees (and/or editors) of the journal cannot be resolved despite all efforts and best of intentions. While the journal-notwithstanding any appeals-retains the right to reject such manuscripts, the editors of this journal may decide, in cases deemed of exceptional interest and potential significance for the field, to accept the manuscript for publication, to amend it by "comments" of the editor(s) in charge and, if appropriate, by a "reply" of the authors of the commented manuscript. The present comment is on "Study of multi-muon events produced in pp̄ interactions at √ = 1.96 TeV"; T. Aaltonen et al. (The CDF Collaboration, Eur. Phys. J. C, 2010, doi:10.1140/epjc/s10052-010-1336-0. © 2010 The Author(s).
- Published
- 2010
4. Intra-abdominal fat distribution assessed by ultrasonography
- Author
-
A. Filippo, C. Novella Casella, A. M. Sidoti, and V. Panetta
- Subjects
Intra-Abdominal Fat ,business.industry ,Medicine ,Distribution (pharmacology) ,Radiology, Nuclear Medicine and imaging ,Ultrasonography ,business ,Nuclear medicine - Published
- 2008
- Full Text
- View/download PDF
5. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules
- Author
-
M, Sidoti, G, Marino, E, Resmini, C, Augeri, C, Cappi, D, Cavallero, C, Lagasio, P, Ceppa, F, Minuto, and M, Giusti
- Subjects
Adult ,Aged, 80 and over ,Male ,Biopsy, Fine-Needle ,Carcinoma ,Thyroid Gland ,Middle Aged ,Sensitivity and Specificity ,Cohort Studies ,Evaluation Studies as Topic ,Predictive Value of Tests ,Thyroidectomy ,Humans ,Female ,Thyroid Neoplasms ,Thyroid Nodule ,Aged ,Ultrasonography - Abstract
Fine needle aspiration biopsy (FNAB) plays a crucial role in the diagnosis of thyroid nodules and enables the number of surgical operations to be reduced. Theoretically, FNAB should be carried out on all nodules, though currently only those displaying certain characteristics are biopsied. Indeed, to perform FNAB on all nodules may be regarded as an excess of zeal. Therefore, it seems advisable that the endocrinologist should be able to confirm on the spot the necessity and utility of FNAB.We evaluated on a sample of 263 consecutive requests (209 female, 57 male; age 56.7+/-13.7 years) for FNAB in 2004: 1) the appropriateness of the investigation, 2) expected efficacy, 3) practical efficacy, 4) efficiency. FNAB was performed under echo-guidance in accordance with the standard technique. In 50%, 36%, 6%, 3%, 2% and 1% of cases, the echographic diagnosis was of MNG, UNG, pseudo-nodular lesion in ATD, lymph-node, neck cyst, suspected parathyroid lesion and tumefaction of the salivary glands, respectively. A pre-FNAB clinical risk score was assigned to each case on the basis of clinical and echographic data, with a maximum possible score of 11. The results of FNAB were subdivided into 5 categories according to the criteria of the BTA (Thy1-Thy5). After FNAB, a decisional category was assigned, ranging from ''observation'' to ''surgery''; this was subsequently (7-18 months) compared with the management strategy adopted by the attending physician. Information was gathered by means of telephone enquiry.1) Appropriateness: on the basis of clinical and echographic findings, FNAB was not judged appropriate in 24% of cases because of either the lack of confirmation of a significant target (34%) or a low pre-FNAB risk score (range 0-2) (66%). The decisional category was ''observation'' in 87% of cases and ''further investigation'' in 13%. 2) Expected efficacy: FNAB was performed in 76% of cases. The biopsies (3%) performed on swollen lymph-nodes and extra-thyroid neck tumefactions, in which biochemical evaluation was positive, proved to be diagnostic but not classifiable according to the BTA. In 82% of the remaining cases, the result was Thy2 (observation) or Thy 4-5 (surgery). Thy3 results (surgery) were rare (1%). Thy1 results (16%) were yielded by the aspiration of colloid cysts (29%), solid lesions (10%) characterised by means of PTH-FNAB and Tg-FNAB, nodules (9%) no longer detectable on repetition of FNAB, nodules (16%) in which FNAB was already a repetition of a non-diagnostic investigation (2003), and nodules (9%) in which the presence of normal thyrocytes, ''hot'' scintigraphic image and prior decision of the surgeon advised against repeating FNAB. Of the patients with Thy1 results, 26% refused to repeat FNAB. In all, 95% of FNAB supported by biochemical evaluation yielded results that usefully contributed to patient management. The correlation between pre-FNAB clinical risk and cytological score according to the BTA proved significant (P0.001). No difference in diameter was recorded between nodules with adequate cytology (23.3+/-0.9 mm) and those with inadequate cytology (25.2+/-1.6 mm). 3) Practical efficacy: 75% of patients were reached by telephone. In most cases, observation was the most frequent clinical choice, after echography and/or FNAB. The decisional category assigned after FNAB correlated significantly (P0.001) with the approach adopted by the attending physician. d) Efficiency: following FNAB, 11 patients were assigned to surgery. DTC was detected in 100% of these cases (1 follicular carcinoma, 1 insular carcinoma, 9 papillary carcinoma). The success of FNAB (9/11) in detecting lesions that proved malignant on histological examination (11/11) was significant (P0.05). Of the 2 Thy 3 cases, 1 was follicular carcinoma and 1 was follicular adenoma with adjacent papillary carcinoma. The incidence of thyroid carcinomas in the population studied was 5.5%.1) Together with clinical-biochemical evaluation, echo-guided FNAB re-mains the first-line diagnostic test in the management of thyroid nodules; 2) a pre-FNAB clinical risk score is useful in limiting the number of probably inappropriate investigations; 3) efficacy, in terms of cytology results that are useful for patient management after FNAB (and after biochemical evaluation, when indicated) is high, enabling patients to be stratified in classes with different subsequent pathways; 4) in the vast majority of cases, FNAB influences subsequent clinical decisions; 5) false negatives cannot be excluded, while false positives are practically nil; 6) further indications may be yielded by studies on larger populations, and new prospects may emerge from the application of other techniques associated to FNAB.
- Published
- 2006
6. Nifedipine and thrombocytopenia
- Author
-
F. Pauselli, A. M. Sidoti, L. Temperilli, and E. Breda
- Subjects
medicine.medical_specialty ,Letter ,Nifedipine ,business.industry ,Internal medicine ,Immunology ,medicine ,MEDLINE ,General Medicine ,business ,medicine.drug - Published
- 1992
7. Lung mechanics in subjects showing increased residual volume without bronchial obstruction
- Author
-
Vulterini S, A M Sidoti, Pellicciotti L, and Bianco Mr
- Subjects
Adult ,Lung Diseases ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Pulmonary compliance ,Elastic recoil ,Functional residual capacity ,Airway resistance ,Forced Expiratory Volume ,Internal medicine ,medicine ,Humans ,Plethysmograph ,Lung volumes ,Expiration ,Lung ,Lung Compliance ,business.industry ,Airway Resistance ,Middle Aged ,respiratory system ,respiratory tract diseases ,Residual Volume ,medicine.anatomical_structure ,Anesthesia ,Cardiology ,Female ,Lung Volume Measurements ,business ,Research Article - Abstract
Fourteen subjects showing an increase of residual volume (RV) without any clinical or functional signs of bronchial obstruction were studied. Maximum expiratory flow volume (MEFV) curves were obtained with a pressure-corrected volume plethysmograph. Static pressure-volume curves were obtained by stepwise interruption of a slow expiration from total lung capacity (TLC) to RV. Static compliance was measured by the slope of pressure-volume curve between functional residual capacity (FRC) and FRC+20% of TLC. Maximum flow static recoil (MFSR) curves were constructed by plotting MEF obtained from MEFV curves against elastic pressure (Pst) obtained from pressure-volume curves at the same lung volumes. Most patients demonstrated a decrease of MEF 50% and 25% of VC. From the MFSR curves it was clear that this reduction was not the result of increased airways resistance, but rather of loss of elastic recoil. Most patients showed a significant decrease of Pst at different volumes and changes seem likely to be evidence of emphysema.
- Published
- 1980
- Full Text
- View/download PDF
8. [Tricholeukemia associated with Kaposi's disease: presentation of a clinical case]
- Author
-
L, Temperilli, E, Breda, A M, Sidoti, and A M, Costa
- Subjects
Leukemia, Hairy Cell ,Skin Neoplasms ,Humans ,Female ,Middle Aged ,Sarcoma, Kaposi - Abstract
A case of hairy cell leukemia (HCL) in a 60-years-old woman is reported. One year after the onset of the disease the patient developed Kaposi's sarcoma. Such uncommon association might be related to lymphocytes deficit induced by HCL.
- Published
- 1989
9. ENDEMIC COGNITIVE AND NEUROMOTOR DEFICIT IN SCHOOLCHILDREN OF IODINE DEFICIENT AREAS
- Author
-
F. De Luca, M. Scaffidi, S Battiato, Francesco Trimarchi, M. Sidoti, M. D. Finocchiaro, Domenica Crupi, and Francesco Vermiglio
- Subjects
endocrine system ,medicine.medical_specialty ,Pediatrics ,Goiter ,endocrine system diseases ,Endemic Cretinism ,business.industry ,Bone age ,Hyporeflexia ,medicine.disease ,Short stature ,Iodine deficiency ,Endocrinology ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Euthyroid ,medicine.symptom ,business ,Cretinism - Abstract
Mental defects were found by Bender-Gestalt test, Santucci method, in 33/192 (17.1 %) euthyroid schoolchildren born between 1975 - 1980 in an endemic goiter and cretinism area in which goiter prevalence was 79% and daily iodine urinary excretion was 22.3 +/- 16.4 mcg.just in the years in which studied children were born. These defects are variously associated with goiter (36.4%), short stature (15.1), bone age retardation (21.2%) and with minor neuromotor disorders including hyporeflexia (21.2), hyperreflexia/clonus of the rotula and or foot (30%), dyslalia (6.1%). These findings could be considered as minor manifestations of neurological endemic cretinism. It must be noted that these defects are not only the clue of that severe endemia since the extension of file study to another community of 119 schoolchildren living in an area with a goiter prevalence of 59% revealed a 12.6% children with comparable mental and neuromotor defects. Despite an actual sharp decrease in goiter prevalence in both areas (79-44%, 59-26%), these iodine deficiency disorders seem to persist hitherto. If neurological damage is due to iodine deficiency “per se” or to maternal hypothyroxinemia is still unclear.
- Published
- 1988
- Full Text
- View/download PDF
10. Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- Author
-
Lazzarotto T, Chiereghin A, Piralla A, Piccirilli G, Girello A, Campanini G, Gabrielli L, Costa C, Prete A, Bonifazi F, Busca A, Cairoli R, Colombo AA, Zecca M, Sidoti F, Bianco G, Paba P, Perno CF, Cavallo R, Baldanti F, AMCLI-GLaIT working group., Lazzarotto T, Chiereghin A, Piralla A, Piccirilli G, Girello A, Campanini G, Gabrielli L, Costa C, Prete A, Bonifazi F, Busca A, Cairoli R, Colombo AA, Zecca M, Sidoti F, Bianco G, Paba P, Perno CF, Cavallo R, Baldanti F, AMCLI-GLaIT working group., Tiziana, L, Angela, C, Antonio, P, Giulia, P, Alessia, G, Giulia, C, Liliana, G, Cristina, C, Arcangelo, P, Francesca, B, Alessandro, B, Cairoli, R, Anna Amelia, C, Marco, Z, Francesca, S, Gabriele, B, Pierpaolo, P, Carlo Federico, P, Rossana, C, and Fausto, B
- Subjects
Adult ,Male ,0301 basic medicine ,Herpesvirus 4, Human ,medicine.medical_specialty ,medicine.medical_treatment ,030106 microbiology ,Congenital cytomegalovirus infection ,Allogeneic hematopoietic stem cell transplantation ,CMV and EBV DNA kinetics ,Plasma ,Whole blood ,Hematology ,Transplantation ,Cytomegalovirus ,Hematopoietic stem cell transplantation ,Virus Replication ,Virus ,03 medical and health sciences ,chemistry.chemical_compound ,Internal medicine ,medicine ,Humans ,Aged ,Retrospective Studies ,CMV and EBV DNA kinetic ,business.industry ,Hematopoietic Stem Cell Transplantation ,virus diseases ,Middle Aged ,Allografts ,medicine.disease ,Virology ,Transplant Recipients ,Kinetics ,Blood ,030104 developmental biology ,chemistry ,Viral replication ,DNA, Viral ,Female ,business ,DNA - Abstract
Currently, no consensus has been reached on the optimal blood compartment to be used for surveillance of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) DNAemia. Although several comparative studies have been performed correlating CMV and EBV DNA loads in whole blood (WB) versus plasma, to our knowledge, no studies to date have analyzed the kinetics of both viruses in the 2 blood compartments. In this retrospective noninterventional multicenter cohort study, the kinetics of CMV and EBV DNA in 121 hematopoietic stem cell transplantation (HSCT) recipients were investigated by analyzing in parallel 569 and 351 paired samples from 80 and 58 sequential episodes of CMV and EBV DNAemia, respectively. Unlike previous studies, this study used a single automated molecular method that was CE-marked and Food and Drug Administration-approved for use in quantifying CMV and EBV DNA in both plasma and WB. Furthermore, the complete viral replication kinetics of all episodes (including both the ascending and the descending phases of the active infection) was examined in each patient. The previously observed overall correlation between CMV DNA levels in WB and plasma was confirmed (Spearman's ρ =.85; P
- Published
- 2018
- Full Text
- View/download PDF
11. Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies
- Author
-
Tiziana Lazzarotto, Angela Chiereghin, Antonio Piralla, Dino Gibertoni, Giulia Piccirilli, Gabriele Turello, Giulia Campanini, Liliana Gabrielli, Cristina Costa, Giorgia Comai, Gaetano La Manna, Luigi Biancone, Teresa Rampino, Marilena Gregorini, Francesca Sidoti, Gabriele Bianco, Maria Vittoria Mauro, Francesca Greco, Rossana Cavallo, Fausto Baldanti, AMCLI-GLaIT, Lazzarotto T, Chiereghin A, Piralla A, Gibertoni D, Piccirilli G, Turello G, Campanini G, Gabrielli L, Costa C, Comai G, La Manna G, Biancone L, Rampino T, Gregorini M, Sidoti F, Bianco G, Mauro MV, Greco F, Cavallo R, Baldanti F, and AMCLI-GLaIT.
- Subjects
0301 basic medicine ,Human cytomegalovirus ,Herpesvirus 4, Human ,Physiology ,Cancer Treatment ,Cytomegalovirus ,030230 surgery ,Pathology and Laboratory Medicine ,medicine.disease_cause ,Gastroenterology ,Cohort Studies ,0302 clinical medicine ,Blood plasma ,Medicine and Health Sciences ,Public and Occupational Health ,Viral ,Cytomegalovirus, Epstein-Barr virus, viral DNA in whole blood, viral DNA in plasma, kidney transplant recipients ,Kidney transplantation ,Virus Testing ,Whole blood ,Multidisciplinary ,virus diseases ,Viral Load ,Vaccination and Immunization ,Body Fluids ,Blood ,Oncology ,Medical Microbiology ,Viral Pathogens ,Viruses ,Medicine ,Human Cytomegalovirus ,Anatomy ,Pathogens ,Viral load ,Immunosuppressive Agents ,Research Article ,Human ,Adult ,Herpesviruses ,medicine.medical_specialty ,Science ,Immunology ,Antiviral Agents ,DNA, Viral ,Humans ,Kinetics ,Retrospective Studies ,Kidney Transplantation ,Congenital cytomegalovirus infection ,Microbiology ,Blood Plasma ,Virus ,03 medical and health sciences ,Antiviral Therapy ,Antibody Therapy ,Diagnostic Medicine ,Virology ,Internal medicine ,medicine ,Epstein-Barr virus ,Microbial Pathogens ,business.industry ,Organisms ,Herpesvirus 4 ,Biology and Life Sciences ,DNA ,medicine.disease ,Epstein–Barr virus ,030104 developmental biology ,Clinical Immunology ,Preventive Medicine ,Clinical Medicine ,DNA viruses ,business ,Viral Transmission and Infection - Abstract
This retrospective multicenter cohort study investigated the kinetics (ascending and descending phases) of cytomegalovirus (CMV) and Epstein-Barr virus (EBV)-DNA in whole blood (WB) and plasma samples collected from adult kidney transplant (KT) recipients. CMV-DNA kinetics according to antiviral therapy were investigated. Three hundred twenty-eight paired samples from 42 episodes of CMV infection and 157 paired samples from 26 episodes of EBV infection were analyzed by a single commercial molecular method approved by regulatory agencies for both matrices. CMV-DNAemia followed different kinetics in WB and plasma. In the descending phase of infection, a slower decay of viral load and a higher percentage of CMV-DNA positive samples were observed in plasma versus WB. In the 72.4% of patients receiving antiviral therapy, monitoring with plasma CMV-DNAemia versus WB CMV-DNAemia could delay treatment interruption by 7-14 days. Discontinuation of therapy based on WB monitoring did not result in relapsed infection in any patients. Highly different EBV-DNA kinetics in WB and plasma were observed due to lower positivity in plasma; EBV positive samples with a quantitative result in both blood compartments were observed in only 11.5% of cases. Our results emphasize the potential role of WB as specimen type for post-KT surveillance of both infections for disease prevention and management.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.